Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Beginners often wonder which card type to choose. This intro compares secured vs unsecured options and provides starter tips.
22,834 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Sleep Number's 2025 earnings story centers on demand shifts, pricing discipline, and inventory health. This guide bre...
Quantum computing is moving from theory to real-world use. In this guide, we break down the three best quantum comput...
A new pediatric guidance warns that american schools have been quietly cutting recess in pursuit of test scores, risk...
U.S. cities are fighting an asphalt industry heat problem by testing permeable pavements and green designs to cool su...
April data show 7.6 million job openings, up from March as hiring slows and layoffs drop. The report highlights a sti...
Geopolitics shape energy markets, and a possible end to the Iran war could shift risks and returns for energy ETFs. T...
July brought mixed signals to the stock market today as entertainment stocks like AMC faced dilution concerns while t...
A low-cost eyewear program is lifting output and reducing mistakes on Bangladesh’s garment floors. Experts say the pe...
Soleno's Q4 2025 earnings paint a picture of growth with new products and expanding margins. This guide breaks down t...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
A new wave in AI infrastructure is building: the million-XPU data center. This article explains what it is, why it ma...